Baltimore County Department of Health

The Food and Drug Administration has granted emergency use authorization to sotrovimab for the treatment of mild to moderate COVID-19 in patients at increased risk for progression to severe illness.Sotrovimab is a monoclonal antibody that works directly against the spike protein of SARS-CoV-2 to block its attachment and entry into a human cell.

An analysis aiming to functionally subgroup seriously conduct disordered adolescents identified grade of onset of persistent classroom misconduct as the single most useful and discriminating variable for this purpose. Students whose misconduct began in the early elementary school were characterized by a prominent degree of developmental-educational limitations, whereas those with a later onset were--like the control group--remarkably free of early risk factors.

(1977). Socioeconomic factors influencing the rate of non‐promotion in elementary schools. Peabody Journal of Education: Vol. 54, No. 4, pp. 275-281.

You are quite correct; the dose of dextroamphetamine was not included in the paper.1 The daily dose range for dextroamphetamine was 5 to 40 mg. The average daily dose was 12.4 mg. Fifty-four percent of the children received this medication during the summer, and 10% received the medication three times daily. There was no significant relationship between the dose of dextroamphetamine and growth suppression, a finding presented in Table IV of the paper. We do not know if doses less than 5 mg daily are nonsuppressive of growth.

Dr. Pushkin enthusiastically reports his program for the use of mouth‐guards in Baltimore County, Maryland.